Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Bullboard (TSX:NUMI)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by AwareInvestoron Mar 15, 2021 9:27am

Numinus Wellness To Conduct $30 Million Bought Deal

Numinus Wellness this morning announced that it will be raising funds again. The latest round being conducted by the company will look to raise $30.0 million in a bought deal offering lead by Eight ...more  
316
Post by stockpatrolon Mar 09, 2021 4:02pm

NUMI expansion

NUMI announces plans to significantly expand its psychedelics research laboratory by late 2021. A 7,500 square foot addition  alongside the expansion, NUMI also receives amendments from Health ...more  
199
Post by AwareInvestoron Mar 09, 2021 8:19am

Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness has expansion on its mind. The company this morning announced that it plans to expand its psychedelics research lab by the end of 2021. https://thedeepdive.ca/numinus-wellness ...more  
152
Post by cresscoon Mar 04, 2021 10:50am

Coiled Spring

Is what this feels like.
118
Comment by cresscoon Mar 04, 2021 9:28am

RE:Major News

Regulatory approvals place Numinus lab at the forefront of global psychedelics research V.NUMI | 1 hour ago Canada NewsWire Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and ...more  
190
Discussion
Post by cresscoon Mar 04, 2021 9:22am

Major News

https://www.stockwatch.com/News/Item?C:NUMI&bid=Z-C:NUMI-3042636
186
Discussion
Post by Alexandchoyon Mar 02, 2021 6:01pm

NUMI is a buy IMO here's why

NUMI’s operational state-of-the art laboratory, specialized equipment and significant expertise in psychedelic research will be critical for Optimi Health to rapidly advance the development of safe ...more  
300
Post by rideitouton Mar 02, 2021 8:20am

Some Tues morning news!

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update (ceo.ca) These clinical trilas are progressing nicely! 
140
Post by Bigballs1974on Feb 25, 2021 12:18pm

IPO

https://twitter.com/AllStreetsWolf/status/1364985437488635906?s=20
154
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities